Protagenic Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -51.4% | -51.4% | -44.2% |
| FY2023 | -136.3% | -136.3% | -115.7% |
| FY2024 | -545.4% | -545.4% | -282.5% |
| FY2025 | 72.5% | 72.5% | -4,031.6% |
| FY2026 | 52.2% | 52.2% | 37.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -51.4% | -51.4% | -44.2% |
| FY2023 | -136.3% | -136.3% | -115.7% |
| FY2024 | -545.4% | -545.4% | -282.5% |
| FY2025 | 72.5% | 72.5% | -4,031.6% |
| FY2026 | 52.2% | 52.2% | 37.5% |